No connection

Search Results

BMEZ vs CET

BMEZ
BlackRock Health Sciences Term Trust
BEARISH
Price
$15.54
Market Cap
$1.57B
Sector
Financial Services
AI Confidence
85%
CET
Central Securities Corporation
BULLISH
Price
$53.05
Market Cap
$1.57B
Sector
Financial Services
AI Confidence
75%

Valuation

P/E Ratio
BMEZ
--
CET
5.8
Forward P/E
BMEZ
--
CET
-408.08
P/B Ratio
BMEZ
--
CET
0.88
P/S Ratio
BMEZ
--
CET
49.16
EV/EBITDA
BMEZ
--
CET
64.13

Profitability

Gross Margin
BMEZ
0.0%
CET
100.0%
Operating Margin
BMEZ
0.0%
CET
74.67%
Profit Margin
BMEZ
0.0%
CET
831.7%
ROE
BMEZ
--
CET
15.8%
ROA
BMEZ
--
CET
0.9%

Growth

Revenue Growth
BMEZ
--
CET
48.4%
Earnings Growth
BMEZ
--
CET
43.6%

Financial Health

Debt/Equity
BMEZ
--
CET
0.0
Current Ratio
BMEZ
--
CET
1.08
Quick Ratio
BMEZ
--
CET
1.08

Dividends

Dividend Yield
BMEZ
8.49%
CET
5.09%
Payout Ratio
BMEZ
846.82%
CET
29.51%

AI Verdict

BMEZ BEARISH

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 1/9, indicating weak fundamental strength. The absence of an Altman Z-Score and all profitability metrics at 0.00% suggest opaque or non-existent earnings power and potential structural risks. Despite a high dividend yield of 8.49%, the unsustainable 846.82% payout ratio and bearish insider activity raise red flags. Combined with negative long-term price performance and lack of analyst coverage, the investment case lacks foundational support.

Strengths
High current dividend yield of 8.49% provides income appeal
Recent short-term price momentum: +16.6% over 6 months
Market cap of $1.57B indicates moderate size and potential liquidity
Risks
Piotroski F-Score of 1/9 signals severe financial weakness
Profit margins at 0.00% across all levels (gross, operating, net)
Extremely high payout ratio (846.82%) threatens dividend sustainability
CET BULLISH

CET presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 5/9 and a massive valuation gap, with a Graham Number of $111.61 and Intrinsic Value of $269.93 against a current price of $53.05. The company maintains a pristine balance sheet with zero debt and strong historical growth, though it is currently facing a severe bearish technical trend (10/100). While the current P/E of 5.80 is highly attractive, the anomalous Forward P/E and profit margin figures suggest potential accounting volatility or one-time events. Overall, the fundamental safety margin provided by the book value and dividend sustainability outweighs the short-term technical weakness.

Strengths
Extreme undervaluation relative to Graham Number ($111.61) and Intrinsic Value ($269.93)
Pristine solvency with a Debt/Equity ratio of 0.00
Strong historical growth with YoY Revenue growth of 48.40% and Earnings growth of 43.60%
Risks
Severe bearish technical trend (10/100) indicating strong short-term selling pressure
Highly anomalous Forward P/E (-408.08) suggesting a projected collapse in earnings
Accounting anomalies evidenced by a mathematically improbable Profit Margin of 831.70%

Compare Another Pair

BMEZ vs CET: Head-to-Head Comparison

This page compares BlackRock Health Sciences Term Trust (BMEZ) and Central Securities Corporation (CET) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile